GTCR Completes Acquisition of Zentiva From Advent to Expand European Generics Platform
September 11, 2025
GTCR has completed its previously announced acquisition of Zentiva, a leading European generics pharmaceutical company, from Advent. The deal expands GTCR’s European generics healthcare platform and is intended to drive growth through continued investment in product development, portfolio breadth, and geographic reach.
- Buyers
- GTCR, GTCR (as acquiring entity)
- Targets
- Zentiva
- Sellers
- Advent International
- Industry
- Pharmaceuticals
- Location
- Czech Republic
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.